Acelrx Pharmaceuticals Inc.

ACRX

2.90

-0.05

-1.7%

Please Login or Register

Login|Register FREE

Stock Price
Open: 2.95
Prev. Close: 2.95
Low/Hi: 2.85 - 3.00
52-Week: 1.55 - 5.75
Volumes
Equity: 347,154
90-Day Avg: 452,252
Option: 229
90-Day Avg: 291
Volatility
Todays Stock Vol: 42.9
20-Day (HV): 73.5
52-Week (HV): 75.1
30-Day IV: 43.3 -28.3
IV Pct Rank: 22% Subdued
Fundamental
Div. Yield:
Earnings: 31-Jul (Est.)
P/E Ratio:
Market Cap: 151.4 M
Short Int Pct: 0.0%
Pct Held By Inst.: 27.4%
Stock Info
Type: Common
Sector: Healthcare
Industry: Medical Appliances & Equipment

About ACRX

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company's late-stage pipeline includes ARX-04 (sufentanil sublingual tablet, 30 mcg) for the treatment of moderate-to-severe acute pain in a medically supervised setting; and Zalviso (sufentanil sublingual tablet system) for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Primary Exchange: NASDAQ
SIC Measuring & Controlling Devices, NEC
NAICS Surgical and Medical Instrument Manufacturing

ACRX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 13.8 B 1.37811E+10 3,460 3460 0.0% 0 41 K 41247
IWC iShares Microcap ETF 991.6 M 9.91612E+08 1,365 1365 0.03% 0.0003 282 K 281504
VTI Vanguard Total Stock Market ETF 93.3 B 9.33E+10 3,629 3629 0.0% 0 321 K 321180
VXF Vanguard Extended Market ETF 5.9 B 5.9E+09 3,259 3259 0.0% 2E-05 110 K 110327
WMCR PowerShares Wilshire Micro-Cap EPortfolio 29.0 M 2.9E+07 791 791 0.11% 0.00109 32 K 31654

Wait, Before You Leave...

Want to Know More About ACRX Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon